Hilden, J M <br/><br/>
Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23).  [electronic resource] 

 -  Blood  Nov 1995 
 - 3876-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Base Sequence<br/>Bone Marrow Transplantation<br/>Chromosomes, Human, Pair 11--ultrastructure<br/>Chromosomes, Human, Pair 4--ultrastructure<br/>Combined Modality Therapy<br/>DNA, Neoplasm--genetics<br/>DNA-Binding Proteins--genetics<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Histone-Lysine N-Methyltransferase<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Molecular Sequence Data<br/>Myeloid-Lymphoid Leukemia Protein<br/>Neoplasm, Residual<br/>Nuclear Proteins--genetics<br/>Oncogene Proteins, Fusion--genetics<br/>Polymerase Chain Reaction<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--genetics<br/>Prognosis<br/>Proto-Oncogenes<br/>Salvage Therapy<br/>Transcription Factors<br/>Transcriptional Elongation Factors<br/>Translocation, Genetic<br/>Treatment Outcome